High-Quality Etamsylate Injection for Human

Product Details
Customization: Available
Application: Coagulant
Usage Mode: I.V./I.M.
Still deciding? Get samples of US$ 2/Piece
Request Sample
Gold Member Since 2020

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
In-stock Capacity
The supplier has In-stock capacity
R&D Capabilities
The supplier has 1 R&D engineers, you can check the Audit Report for more information
to see all verified strength labels (9)
  • High-Quality Etamsylate Injection for Human
  • High-Quality Etamsylate Injection for Human
  • High-Quality Etamsylate Injection for Human
  • High-Quality Etamsylate Injection for Human
  • High-Quality Etamsylate Injection for Human
  • High-Quality Etamsylate Injection for Human
Find Similar Products

Basic Info.

Model NO.
NO.
State
Liquid
Shape
Liquid
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
Available
Drug Ad Approval No.
Available
Standard
Bp. USP.
Storage
Cool & Dry Place
Sample
Available
Shelf Life
2 Years
Transport Package
Vial/Box/Carton
Specification
500mg: 2ml/250mg: 2ml
Trademark
OEM
Origin
China
Production Capacity
50000 Boxes/Week

Product Description

Product Information:
Product name Etamsylate Injection
Specification 500mg:2ml/250mg:2ml
Packing Customizable
Sample Available
OEM Available
Storage Cool and Dry place
Shelf life 2 Years
Application Coagulant

Indication:

It can be used to prevent and treat bleeding before and after various operations, and it can also be used for bleeding caused by poor platelet function and increased vascular fragility.

Usage and dosage:

1. Intramuscular or intravenous injection of 0.25-0.5g once, 0.5-1.5g a day. Intravenous drip: 0.25-0.75g once, 2-3 times a day, diluted and drip.
2. To prevent postoperative bleeding, 0.25-0.5g was given intravenously or intramuscularly 15-30 minutes before operation, and 0.25g was given 2 hours later if necessary.

Adverse reactions:

This product has low toxicity, nausea, headache, rash, temporary hypotension, and occasionally anaphylactic shock after intravenous injection.

Matters needing attention:

This product can be mixed with vitamin K injection, but not with aminocaproic acid injection.

Pharmacology and Toxicology:

This product can make blood vessels constrict, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelet to release clotting active substances, shorten clotting time, and achieve hemostatic effect. The plasma concentration reached the peak one hour after intravenous injection, and the effect lasted for 4-6 hours. Most of them were excreted from the kidney in the original form, and a small part was excreted from bile and feces.
High-Quality Etamsylate Injection for Human
High-Quality Etamsylate Injection for Human
High-Quality Etamsylate Injection for Human
High-Quality Etamsylate Injection for Human
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier